End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapy

Abstract Autosomal dominant polycystic kidney disease (ADPKD) is commonly caused by PKD1, and mosaic PKD1 variants result in milder phenotypes. We present the case of a 32 year-old male with chronic active Epstein–Barr virus who underwent bone marrow transplantation with chemoradiotherapy at age 9....

Full description

Bibliographic Details
Main Authors: Hiroaki Hanafusa, Hiroshi Yamaguchi, Naoya Morisada, Ming Juan YE, Riki Matsumoto, Hiroaki Nagase, Kandai Nozu
Format: Article
Language:English
Published: Nature Publishing Group 2024-03-01
Series:Human Genome Variation
Online Access:https://doi.org/10.1038/s41439-024-00273-0
_version_ 1797233652994670592
author Hiroaki Hanafusa
Hiroshi Yamaguchi
Naoya Morisada
Ming Juan YE
Riki Matsumoto
Hiroaki Nagase
Kandai Nozu
author_facet Hiroaki Hanafusa
Hiroshi Yamaguchi
Naoya Morisada
Ming Juan YE
Riki Matsumoto
Hiroaki Nagase
Kandai Nozu
author_sort Hiroaki Hanafusa
collection DOAJ
description Abstract Autosomal dominant polycystic kidney disease (ADPKD) is commonly caused by PKD1, and mosaic PKD1 variants result in milder phenotypes. We present the case of a 32 year-old male with chronic active Epstein–Barr virus who underwent bone marrow transplantation with chemoradiotherapy at age 9. Despite a low-frequency mosaic splicing PKD1 variant, he developed severe renal cysts and end-stage renal disease in his 30 s. This case highlights how environmental factors may contribute to the genetic predisposition to ADPKD.
first_indexed 2024-04-24T16:19:35Z
format Article
id doaj.art-40fae847fbc140e1944c6d8d4bcb8911
institution Directory Open Access Journal
issn 2054-345X
language English
last_indexed 2024-04-24T16:19:35Z
publishDate 2024-03-01
publisher Nature Publishing Group
record_format Article
series Human Genome Variation
spelling doaj.art-40fae847fbc140e1944c6d8d4bcb89112024-03-31T11:14:18ZengNature Publishing GroupHuman Genome Variation2054-345X2024-03-011111310.1038/s41439-024-00273-0End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapyHiroaki Hanafusa0Hiroshi Yamaguchi1Naoya Morisada2Ming Juan YE3Riki Matsumoto4Hiroaki Nagase5Kandai Nozu6Department of Pediatrics, Kobe University Graduate School of MedicineDepartment of Pediatrics, Kobe University Graduate School of MedicineDepartment of Genetics, Hyogo Prefectural Kobe Children’s HospitalDepartment of Pediatrics, Kobe University Graduate School of MedicineDepartment of Neurology, Kobe University Graduate School of MedicineDepartment of Pediatrics, Kobe University Graduate School of MedicineDepartment of Pediatrics, Kobe University Graduate School of MedicineAbstract Autosomal dominant polycystic kidney disease (ADPKD) is commonly caused by PKD1, and mosaic PKD1 variants result in milder phenotypes. We present the case of a 32 year-old male with chronic active Epstein–Barr virus who underwent bone marrow transplantation with chemoradiotherapy at age 9. Despite a low-frequency mosaic splicing PKD1 variant, he developed severe renal cysts and end-stage renal disease in his 30 s. This case highlights how environmental factors may contribute to the genetic predisposition to ADPKD.https://doi.org/10.1038/s41439-024-00273-0
spellingShingle Hiroaki Hanafusa
Hiroshi Yamaguchi
Naoya Morisada
Ming Juan YE
Riki Matsumoto
Hiroaki Nagase
Kandai Nozu
End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapy
Human Genome Variation
title End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapy
title_full End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapy
title_fullStr End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapy
title_full_unstemmed End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapy
title_short End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapy
title_sort end stage adpkd with a low frequency pkd1 mosaic variant accelerated by chemoradiotherapy
url https://doi.org/10.1038/s41439-024-00273-0
work_keys_str_mv AT hiroakihanafusa endstageadpkdwithalowfrequencypkd1mosaicvariantacceleratedbychemoradiotherapy
AT hiroshiyamaguchi endstageadpkdwithalowfrequencypkd1mosaicvariantacceleratedbychemoradiotherapy
AT naoyamorisada endstageadpkdwithalowfrequencypkd1mosaicvariantacceleratedbychemoradiotherapy
AT mingjuanye endstageadpkdwithalowfrequencypkd1mosaicvariantacceleratedbychemoradiotherapy
AT rikimatsumoto endstageadpkdwithalowfrequencypkd1mosaicvariantacceleratedbychemoradiotherapy
AT hiroakinagase endstageadpkdwithalowfrequencypkd1mosaicvariantacceleratedbychemoradiotherapy
AT kandainozu endstageadpkdwithalowfrequencypkd1mosaicvariantacceleratedbychemoradiotherapy